🇺🇸 FDA
Patent

US 10849896

Sortilin-binding small molecules for increasing glucose uptake

granted A61KA61K31/197A61K31/4035

Quick answer

US patent 10849896 (Sortilin-binding small molecules for increasing glucose uptake) held by United States Government as represented by the Department of Veterans Affairs expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/197, A61K31/4035, A61K31/498, A61K38/00